Nasopharyngeal carcinoma‑associated gene 6 inhibits cell viability, migration, invasion and induces apoptosis in osteosarcoma cells by inactivating the Wnt/β‑catenin signaling pathway

Liu,Lun; Wang,Ruijing; Zhang,Zian; Wang,Xiangda

doi:10.3892/mmr.2020.11732

Nasopharyngeal carcinoma‑associated gene 6 inhibits cell viability, migration, invasion and induces apoptosis in osteosarcoma cells by inactivating the Wnt/β‑catenin signaling pathway

Authors:
- Lun Liu
- Ruijing Wang
- Zian Zhang
- Xiangda Wang
View Affiliations

Affiliations: Department of Joint Surgery, Qingdao West Coast Hospital, Affiliated Hospital of Qingdao University, Qingdao, Shandong 266555, P.R. China, Department of Surgery, Qingdao West Coast Hospital, Affiliated Hospital of Qingdao University, Qingdao, Shandong 266555, P.R. China
Published online on: November 25, 2020 https://doi.org/10.3892/mmr.2020.11732
Article Number: 93

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Nasopharyngeal carcinoma‑associated gene 6 (NGX6) is associated with the Wnt/β‑catenin signaling pathway in a number of different types of cancer, including colorectal cancer (CRC). The present study is aimed to determine the functional role of NGX6 in osteosarcoma (OS) and to investigate the underlying mechanism associated with the Wnt/β‑catenin signaling pathway. NGX6 expression levels in tissues derived from patients with OS and cell lines (MG‑63, Saos‑2, U2OS and HOS) was analyzed using reverse transcription‑quantitative PCR. NGX6 expression levels were subsequently overexpressed through transfection of the pcDNA3.1 (pcDNA)‑NGX6 overexpression vector into U2OS and HOS cells. BML284 was utilized to activate the Wnt/β‑catenin signaling pathway. MTT, wound healing, Transwell and flow cytometry assays were performed to analyze cell viability, migration, invasion and apoptosis, respectively. Western blotting was also used to analyze the protein expression levels of β‑catenin, c‑Jun and c‑Myc. A xenograft model was constructed by injecting pcDNA‑NGX6‑transfected U2OS cells into nude mice (BALB/c). The results of the present study revealed that the expression levels of NGX6 were downregulated in OS tissues and cell lines. The transfection of pcDNA‑NGX6 into OS cells significantly inhibited the cell viability, and migratory and invasive abilities, and induced the apoptosis of U2OS and HOS cells. The expression levels of β‑catenin, c‑Jun and c‑Myc were also significantly downregulated in pcDNA‑NGX6‑transfected U2OS and HOS cells. Notably, the treatment of transfected cells with BML284 significantly reversed the inhibitory effect of pcDNA‑NGX6 on the viability, migration and invasion, and the promoting effect on apoptosis in U2OS cells. Furthermore, NGX6 overexpression also discovered to inhibit the growth of xenograft tumors in vivo by inhibiting the Wnt/β‑catenin signaling pathway. In conclusion, the findings of the present study suggested that NGX6 may suppress the viability, migration and invasion, while facilitating the apoptosis of OS cells via blocking the Wnt/β‑catenin signaling pathway.

View Figures

View References

1	Biermann JS, Chow W, Reed DR, Lucas D, Adkins DR, Agulnik M, Benjamin RS, Brigman B, Budd GT, Curry WT, et al: NCCN Guidelines Insights: Bone Cancer, Version 2.2017. J Natl Compr Canc Netw. 15:155–167. 2017. View Article : Google Scholar : PubMed/NCBI
2	Mirabello L, Troisi RJ and Savage SA: Osteosarcoma incidence and survival rates from 1973 to 2004: Data from the Surveillance, Epidemiology, and End results program. Cancer. 115:1531–1543. 2010. View Article : Google Scholar
3	Siegel HJ and Pressey JG: Current concepts on the surgical and medical management of osteosarcoma. Expert Rev Anticancer Ther. 8:1257–1269. 2008. View Article : Google Scholar : PubMed/NCBI
4	Mialou V, Philip T, Kalifa C, Perol D, Gentet JC, Marec-Berard P, Pacquement H, Chastagner P, Defaschelles AS and Hartmann O: Metastatic osteosarcoma at diagnosis: Prognostic factors and long-term outcome-the French pediatric experience. Cancer. 104:1100–1109. 2010. View Article : Google Scholar
5	Friebele JC, Peck J, Pan X, Abdel-Rasoul M and Mayerson JL: Osteosarcoma: A meta-analysis and review of the literature. Am J Orthop (Belle Mead NJ). 44:547–553. 2015.PubMed/NCBI
6	Ma J, Li J, Zhou J, Li XL, Tang K, Zhou M, Yang JB, Yan Q, Shen SR, Hu GX and Li GY: Profiling genes differentially expressed in NGX6 overexpressed nasopharyngeal carcinoma cells by cDNA array. J Cancer Res Clin Oncol. 128:683–690. 2002. View Article : Google Scholar : PubMed/NCBI
7	He S, Zhong Y, Shuai C, Gao D, Wei P, Li G and Peng S: Tumor suppressor NGX6 inhibits the growth and metastasis of multiple cancers. Tumour Biol. 37:5751–5760. 2016. View Article : Google Scholar : PubMed/NCBI
8	Wang L, Ma J, Li J, Li X, Zhang Q, Peng S, Peng C, Zhou M, Xiong W, Yang J, et al: NGX6 gene inhibits cell proliferation and plays a negative role in EGFR pathway in nasopharyngeal carcinoma cells. 95:64–73. 2005.PubMed/NCBI
9	Zhang XM, Wang XY, Sheng SR, Wang JR and Li J: Expression of tumor related genes NGX6, NAG-7, BRD7 in gastric and colorectal cancer. World J Gastroenterol. 9:1729–1733. 2003. View Article : Google Scholar : PubMed/NCBI
10	Guo Q, Shen S, Liao M, Lian P and Wang X: NGX6 inhibits cell invasion and adhesion through suppression of Wnt/beta-catenin signal pathway in colon cancer. Acta Biochim Biophys Sin (Shanghai). 42:450–456. 2010. View Article : Google Scholar : PubMed/NCBI
11	Wang YT, Sun XY, Wang H, Huang TT, Wang Y and Yang MX: Effects of NGX6 expression on proliferation and invasion of nasopharyngeal carcinoma cells and survival of patients. Eur Rev Med Pharmacol Sci. 21:5378–5385. 2017.PubMed/NCBI
12	Liu J, Zhu X, Xu X and Dai D: DNA promoter and histone H3 methylation downregulate NGX6 in gastric cancer cells. Med Onco. 31:8172014. View Article : Google Scholar
13	Lin ZF, Shen XY, Lu FZ, Ruan Z, Huang HL and Zhen J: Reveals new lung adenocarcinoma cancer genes based on gene expression. Eur Rev Med Pharmacol Sc. 16:1249–1256. 2012.
14	Nusse R and Clevers H: Wnt/β-catenin signaling, disease, and emerging therapeutic modalities. Cell. 169:985–999. 2017. View Article : Google Scholar : PubMed/NCBI
15	Lin CH, Ji T, Chen CF and Hoang BH: Wnt signaling in osteosarcoma. Adv Exp Med Biol. 804:33–45. 2014. View Article : Google Scholar : PubMed/NCBI
16	Anastas JN and Moon RT: WNT signalling pathways as therapeutic targets in cancer. Nat Rev Cancer. 13:11–26. 2013. View Article : Google Scholar : PubMed/NCBI
17	Takebe N, Miele L, Harris PJ, Jeong W, Bando H, Kahn M, Yang SX and Ivy SP: Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: Clinical update. Nat Rev Clin Oncol. 12:445–464. 2015. View Article : Google Scholar : PubMed/NCBI
18	Zou J, Zhang W and Li XL: Effects of SOST gene silencing on proliferation, apoptosis, invasion, and migration of human osteosarcoma cells through the Wnt/β-catenin signaling pathway. Calcif Tissue Int. 100:551–564. 2017. View Article : Google Scholar : PubMed/NCBI
19	Tang L, Wang D and Gu D: Knockdown of Sox2 inhibits OS cells invasion and migration via modulating Wnt/beta-catenin signaling pathway. Pathol Oncol Res. 24:907–913. 2018. View Article : Google Scholar : PubMed/NCBI
20	Clark DJ, Gebhart FG, Gonder CJ, Keeling ME and Kohn DF: Special Report: The 1996 Guide for the Care and Use of Laboratory Animals. ILAR J. 38:41–48. 1997. View Article : Google Scholar : PubMed/NCBI
21	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
22	Liu M, Peng Y, Wang X, Guo Q, Shen S and Li G: NGX6 gene mediated by promoter methylation as a potential molecular marker in colorectal cancer. Bmc Cancer. 10:160. 2010. View Article : Google Scholar : PubMed/NCBI
23	Xiao JD and Shen SR: Expression and significance of NGX6 gene in human hepatocellular carcinoma. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 33:937–941. 2008.(In Chinese). PubMed/NCBI
24	Peng SP, Li XL, Wang L, Ou-Yang J, Ma J, Wang LL, Liu HY, Zhou M, Tang YL, Li WS, et al: The role of NGX6 and its deletion mutants in the proliferation, adhesion and migration of nasopharyngeal carcinoma 5-8F cells. Oncology. 71:273–281. 2006. View Article : Google Scholar : PubMed/NCBI
25	Logan CY and Nusse R: The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol. 20:781–810. 2004. View Article : Google Scholar : PubMed/NCBI
26	Ma Y, Zhu B, Liu X, Yu H, Yong L, Liu X, Shao J and Liu Z: Inhibition of oleandrin on the proliferation show and invasion of osteosarcoma cells in vitro by suppressing Wnt/β-catenin signaling pathway. J Exp Clin Cancer Res. 34:1152015. View Article : Google Scholar : PubMed/NCBI
27	Li R, Liu J, Wu H, Liu L, Wang L and Zhang S: TIKI2 suppresses growth of osteosarcoma by targeting Wnt/β-catenin pathway. Mol Cell Biochem. 392:109–116. 2014. View Article : Google Scholar : PubMed/NCBI
28	Lv Z, Wang C, Yuan T, Liu Y, Song T, Liu Y, Chen C, Yang M, Tang Z, Shi Q and Weng Y: Bone morphogenetic protein 9 regulates tumor growth of osteosarcoma cells through the Wnt/β-catenin pathway. Oncol Rep. 31:989–994. 2014. View Article : Google Scholar : PubMed/NCBI
29	Guan H, Tan P, Xie L, Mi B, Fang Z, Li J, Yue J, Liao H and Li F: FOXO1 inhibits osteosarcoma oncogenesis via Wnt/β-catenin pathway suppression. Oncogenesis. 4:e1662015. View Article : Google Scholar : PubMed/NCBI
30	Guo Q, Wu M, Lian P, Liao M, Xiao Z, Wang X and Shen S: Synergistic effect of indomethacin and NGX6 on proliferation and invasion by human colorectal cancer cells through modulation of the Wnt/beta-catenin signaling pathway. Mol Cell Biochem. 330:71–81. 2009. View Article : Google Scholar : PubMed/NCBI
31	Liu F, Sheng S, Wang X, Peng Y, Guo Q, Xiao Z and Liu J: Role of NGX6 in Wnt/β-catenin signaling pathway in colon cancer. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 36:235–242. 2011.(In Chinese). PubMed/NCBI